Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Depreciation & Amortization (CF) (2019 - 2025)

Avai Bio's Depreciation & Amortization (CF) history spans 5 years, with the latest figure at $47267.0 for Q1 2024.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 1135.74% to $47267.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $76953.0, a 228.62% increase, with the full-year FY2025 number at $74320.0, down 3.42% from a year prior.
  • Depreciation & Amortization (CF) hit $47267.0 in Q1 2024 for Avai Bio, up from $10268.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for AVAI hit a ceiling of $47267.0 in Q1 2024 and a floor of -$75280.0 in Q1 2020.
  • Historically, Depreciation & Amortization (CF) has averaged $4503.1 across 4 years, with a median of $9684.5 in 2023.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 1667.68% in 2020 and later skyrocketed 1135.74% in 2024.
  • Tracing AVAI's Depreciation & Amortization (CF) over 4 years: stood at $18812.0 in 2020, then crashed by 79.67% to $3825.0 in 2022, then surged by 168.44% to $10268.0 in 2023, then surged by 360.33% to $47267.0 in 2024.
  • Business Quant data shows Depreciation & Amortization (CF) for AVAI at $47267.0 in Q1 2024, $10268.0 in Q4 2023, and $10317.0 in Q3 2023.